Sofiget 400 mg Tablet
Sofiget 400 mg Tablet
Sofiget 400 mg Tablet
Sofiget 400 mg Tablet

Sofiget 400 mg Tablet – Sofosbuvir for Chronic Hepatitis C

  • Antiviral tablet (sofosbuvir 400 mg) for chronic hepatitis C virus infection
  • Once‑daily, in combination regimen, to improve liver health and reduce viral load
In stock
9 People are viewing this right now
Sale price Rs.3,500.00 PKR
Add to Wishlist

Sofiget 400 mg Tablet

Sofiget 400 mg Tablet – Sofosbuvir for Chronic Hepatitis C

Rs.3,500.00

Sofiget 400 mg Tablet – Essential Antiviral for Hepatitis C Treatment

Sofiget 400 mg Tablet contains the active ingredient Sofosbuvir, a potent nucleotide analogue inhibitor of the HCV NS5B RNA‑dependent RNA polymerase. It prevents viral replication by acting as a chain terminator after incorporation into viral RNA.
This medication is indicated for treating chronic hepatitis C infection (CHC) in adults as part of a combination antiviral regimen. It is manufactured by Getz Pharma.

  • Highly effective in inhibiting HCV replication via NS5B polymerase inhibition.
  • Once‑daily dosing simplifies adherence.
  • Clinically proven to lead to sustained virologic response (SVR) with appropriate regimen.
  • Oral administration (tablet) avoids injections.
  • Manufactured by a reputable pharmaceutical company.

  1. Take one tablet (400 mg) orally once daily, with or without food, unless otherwise directed.
  2. Swallow the tablet whole with a glass of water.
  3. Follow the entire prescribed treatment course (usually 12–24 weeks depending on genotype and combination therapy).
  4. Do not skip doses and do not stop treatment prematurely even if you feel better.
  5. If you miss a dose and remember soon, take as soon as possible unless it is close to the next dose — then resume as scheduled. Always follow your physician’s guidance.

Q: What exactly is Sofiget used for?
A: It’s used for treating chronic hepatitis C virus infection in adults, as a component of a combination antiviral regimen.


Q: Can I use this medicine alone to treat hepatitis C?
A: No, Sofiget must be used in combination with other HCV‑direct acting antivirals or as prescribed; monotherapy is not recommended.


Q: How soon will I see results?
A: Viral load reduction may begin within weeks, but full treatment duration (12–24 weeks) is required to achieve sustained virologic response (SVR).


Q: Are there significant side effects?
A: Side effects can include fatigue, headache, nausea, insomnia, and other symptoms.


Q: Can both men and women take it?
A: Yes — but women of childbearing potential should use effective contraception during and after treatment as advised by doctor.

Active: Sofosbuvir 400 mg (each film‑coated tablet)
Excipients: Includes film coating and other pharmacologically inactive components as per the product leaflet.

  • Only used under prescription by a qualified healthcare professional and always in combination with other antiviral agents as advised.
  • Not recommended as monotherapy; effectiveness depends on proper combination with other HCV drugs.
  • Patients with significant renal impairment or undergoing dialysis must use caution; the data in these populations is limited.
  • Monitor liver function, especially in patients with decompensated liver disease or cirrhosis.
  • Pregnancy and breastfeeding: Use only if clearly needed, with physician oversight.

Recently viewed products